Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05a41fe616852000e31287401ad97272 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_65187733d5261d8cf272e78dad762cc3 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-141 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-31 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2330-10 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6809 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-111 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1135 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-713 |
filingDate |
2011-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4fd7073afa496d32813a7cfd1989dc96 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06b086bea70b9fac62573bbb0dfbb66b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_43991d21faea77fcad39c3daca20c369 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_028092e9cb15bb8165635d89f018c8de http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fec112a5af97e7c4cf4da6ea63f6e4ae http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18fd8eb4be12bc30a1d2dc618e2af7fc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d5a12d9e23bf908b4d1b3566a48353c4 |
publicationDate |
2013-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-2591106-A1 |
titleOfInvention |
Mirna and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated braf pathway |
abstract |
The invention relates to the diagnostic and therapeutic uses of a miRNA molecule, an equivalent or a source thereof in a disease and condition associated with melanoma or a disease or a condition associated with activated BRAF pathway. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4035659-A1 |
priorityDate |
2010-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |